Celgene Corp. /de/, 10% Owner at Alliqua BioMedical, Inc. (ALQA), bought 4,000,000 shares at $0.50 ($2.0M) on 2017-02-27, disclosed to the SEC on 2017-03-01.
Open-market purchase of $2.0M ALQA by 10% Owner. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade D.
Nothing distinguishes this filing.
| Filing → |
| XLRN | BUY | 2019-01-22 | $30.4M | — | Filing → |
| AGIO | BUY | 2018-01-23 | $57.0M | — | Filing → |
| CRSP | SELL | 2017-12-07 | $19.6M | — | Filing → |